SCHEMBL25554343

SCHEMBL25554343

CC(CC(=O)CC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.54
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CTSK P43235 9/20 0.42
CTSS P25774 4/20 0.41
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA12 O43570 1/20 0.37
CA14 Q9ULX7 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24345707 1.00 CYP2D6 (0.54) CYP2D6CA1CA2CA7CTSK
SCHEMBL8972253 0.87 CYP2D6 (0.63) CYP2D6CA1CA2CA7CTSK
SCHEMBL27426180 0.87 CYP2D6 (0.63) CYP2D6CA1CA2CA7CTSK
SCHEMBL17034685 0.87 CYP1A2 (0.50) CYP2D6CA1CA2CA7CTSK
SCHEMBL4766284 0.86 CA1 (0.47) CYP2D6CA1CA2CA7CTSK
SCHEMBL25319889 0.83 CA1 (0.47) CYP2D6CA1CA2CA7CTSK
SCHEMBL25319893 0.83 CA1 (0.47) CYP2D6CA1CA2CA7CTSK
SCHEMBL29689264 0.82 CYP2D6 (0.53) CYP2D6CA1CA2CA7CTSK
SCHEMBL2385474 0.82 CYP2D6 (0.53) CYP2D6CA1CA2CA7CTSK
SCHEMBL1369011 0.82 CYP2D6 (0.53) CYP2D6CA1CA2CA7CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116547287-A Inhibitors of APOL1 and methods of use thereof 弗特克斯药品有限公司 2023-08-04 CN disclosed
WO-2023101981-A1 SPIROCYCLIC INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-06-08 WO disclosed
WO-2023102022-A1 4-PHENYL-2-(1H-1,2,3-TRIAZOL-4-YL)PIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-06-08 WO disclosed